A comparison of Doppler flowmetry with conventional assessment of acute changes in hepatic blood flow

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 1, 1996, Pages 14-20

  Gibson, Peter R ^a,c   Gibson, Robert N ^a   Donlan, John D ^a   Jones, Penelope A ^b   Colman, John C ^b   Dudley, Francis J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cirrhosis; Doppler; Drug therapy; Indocyanine green; Portal hypertension; Serotonin antagonist; Ultrasound

Indexed keywords

INDOCYANINE GREEN; KETANSERIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; HEMODYNAMICS; HUMAN; LIVER BLOOD FLOW; MALE; ORAL DRUG ADMINISTRATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; SYSTEMIC CIRCULATION; VASCULAR RESISTANCE;

EID: 0029912539     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00004.x     Document Type: Article

References (16)

1. Lebrec D, Poynard T, Hillou P, Benhamou JP. Propranolol for prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis. N. Engl. J. Med. 1991; 305: 1371-4.
2. Gibson PR, Dudley FJ. Pathophysiology of portal hypertension and implications for its pharmacological control. Aust. N.Z. J. Med. 1989; 19: 172-82.
3. Cales P, Braillon A, Jiron MI, Lebrec D. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. J. Hepatol. 1984; 1: 37-46.
4. Bosch J, Masti R, Kravetz D et al. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 1984; 4: 1200-5.
5. Bosch J, Groszmann RJ. Measurement of azygos venous blood flow by a continuous thermal dilution technique: An index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 1984; 4: 424-9.
6. Gill RW. Measurement of blood flow by ultrasound: Accuracy and sources of error. Ultrasound Med. Biol. 1985; 11: 625-41.
7. Burns P, Taylor K, Blei AT. Doppler flowmetry and portal hypertension. Gastroenterology 1987; 92: 824-6.
8. Burns PN, Jaffe CC. Quantitative flow measurements with Doppler ultrasound: Techniques, accuracy and limitations. Radiol. Clin. North Am. 1985; 23: 641-57.
9. Bolondi L, LiBassi S, Gaiani S, Barbara L. Doppler flowmetry in portal hypertension. J. Gastroenterol. Hepatol. 1990; 5: 459-67.
10. The value of Doppler US in the study of hepatic hemodynamics. Consensus conference (Bologna, Italy, 12 September, 1989). J. Hepatol. 1990; 10: P353-5.
11. Gibson RN, Gibson PR, Donlan JD, Padmanabhan R. Modified Doppler flowmetry in the splanchnic circulation. Gastroenterology 1993; 105: 1029-34.
12. Colman J, Jones P, Jennings G, Debinski H, Finch C, Dudley F. Dose-dependent effects of ketanserin on splanchnic and systemic haemodynamics in cirrhosis (Abstract). Hepatology 1991; 4: 237A.
13. Gibson PR, Fraser JRE, Brown TJ et al. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology 1992; 15: 1054-9.
14. Gaiani S, Bolondi L, Fenyves D, Zironi G, Rigamonti A, Barbara L. Effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Hepatology 1991; 14: 824-9.
15. Hadengue A, Lee SS, Moreau R, Braillon A, Lebrec D. Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: Possible role of serotinergic mechanisms in portal hypertension. Hepatology 1987; 7: 644-7.
16. Hadengue A, Moreau R, Cerini R, Koshy A, Lee SS, Lebrec D. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: Search for an additive effect. Hepatology 1989; 9: 83-7.